ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CVSG Cvs Group Plc

954.00
5.00 (0.53%)
Last Updated: 16:07:57
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.53% 954.00 951.00 956.00 996.00 941.00 996.00 391,692 16:07:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 608.3M 41.9M 0.5843 16.38 686.29M
Cvs Group Plc is listed in the Veterinary Svcs-animal Specs sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 949p. Over the last year, Cvs shares have traded in a share price range of 905.00p to 2,226.00p.

Cvs currently has 71,712,970 shares in issue. The market capitalisation of Cvs is £686.29 million. Cvs has a price to earnings ratio (PE ratio) of 16.38.

Cvs Share Discussion Threads

Showing 576 to 598 of 975 messages
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older
DateSubjectAuthorDiscuss
04/7/2019
21:11
JOSEKI , You and I appear to have a different approach to research, we are probably both right.. If it works stick with it.. Obviously we can learn from each other and that is what maters. I have been learning for 40 years and still am. GOOD HUNTING.
bramble13
04/7/2019
18:15
I don't disagree except sometimes declining P/E doesn't make one immune to value traps. It does apply but depending on nature of company and sector.

In the case here, look at the net CFO and with more controlled capex in future what that then means for FCF and ROE. The business top line has done okay in revenue hence the profit and margins are aligned to be positive.

j0sekl
04/7/2019
07:15
Historic values like P/E..PEG and growth over five years give a very good clue as to the health of a company..they have served me extremely well in the past ....We know the past but guess the future, however good your chystal ball is.
bramble13
03/7/2019
19:13
Focus on execution and fiscally-managed growth. Work your way back to forward P/E rather than historical
j0sekl
03/7/2019
13:08
With a P/E of 17.6, historic P/E has an average of 24.1....I my calculations are that the price could easily reach 900p
bramble13
03/7/2019
07:41
EAH Peel Hunt Buy 600.0 Reiterates




CVSG Peel Hunt Buy 775.00 - Reiterates

grupo
28/6/2019
13:26
The negativity earlier this year included some confusion over why previous reporting disappointed and what were the key strengths.

Unless people stop owning pets, the convenience factor will continue to allow for penetration growth.

Brexit will eventually resolve and the management team are aware of previous spending levels. It's an easy improvement.

j0sekl
28/6/2019
07:24
Encouraging update!
lomax99
12/5/2019
08:28
Can you confirm the names in all positions so we know for sure who you refer to?

Have you brought this forward to the FCA?

--------
To make matters even more incredible CVS’s biggest shareholder Invesco Perpetual and ex-employer to CVS’s Chairman, both directors are budies from PWC audit days) somehow had the timely and opportunistic knack to dump 35 million pounds worth of shares in CVS,

co-incidentally seen recent resignation of their current and last company secretaries and head of legal services

j0sekl
10/5/2019
06:54
Why is the City still smarting over CVS Vets and Dignity Funerals? CVS have made great stock, in the past, of bench marking against sister company Dignity Funerals. Then in late 2016 Dignity was on the skids, with questionable practices and pricing and a UK Government investigation by the CMA into the market.The writing was on the wall at Dignity Funeral, it’s shares crashed catastrophically and are now worth 25% of its original share price high. The joint (CVS/Dignity) executives and other directors, seeing the ensuing blood bath and contagion spreading seemingly dumped their shares in CVS vets netting themselves personally millions of pounds. To make matters even more incredible CVS’s biggest shareholder Invesco Perpetual and ex-employer to CVS’s Chairman, both directors are budies from PWC audit days) somehow had the timely and opportunistic knack to dump 35 million pounds worth of shares in CVS, with no questions asked from regulators!CVS Shares have gone down by 2/3rds For shareholders like me who invested in CVS pre their collapse in share price, we are unhappy and asking many difficult questions, which CVS won’t answer! Indeed, I’ve got the needle on CVS and asking all sorts of questions of the senior executives, which has co-incidentally seen recent resignation of their current and last company secretaries and head of legal services (who partly carry the can!) Draw your own conclusions! I've been writing to CVS and asking the dfficult questions and would like to share my further and quite staggering findings into CVS
gilessaint
03/5/2019
15:02
Just bought into this at 660p - seems to be of good value. Fingers crosses.
btfd497
01/4/2019
20:24
5% increase in share price from 2pm onwards (9am New York time). 2+2=?
grim
01/4/2019
20:24
5% increase in share price from 2pm onwards (9am New York time). 2+2=?
grim
29/3/2019
16:16
The rise is a mirror of the size of the previous drop which was way bigger. If they can convert margin improvements, stop splashing cash and begin growing earnings with their decent presence this might move back into the growth premium price range it used to enjoy.. maybe
j0sekl
29/3/2019
13:31
CVS Group PLC (CVSG:LSE): Last: 615.50, up 98.5 (+19.05%), High: 621.00, Low: 542.50, Volume: 1.11m

BE
The trading update with the interims reads better than expected, with a pick-up in LFL sales, improvement in gross margin and reduction in vacancy rate. This does not remove the issues, but certainly eases any concerns regarding short term issues and the balance sheet. LFL sales in practices +3.2% in H1, with Jan/Feb +c5% helped by price increases and milder weather. We are nudging up our PBT forecast by 3%-5% to reflect the recent improvements. The shares continue to look exceptional value on 8x EV/Ebitda to June 2020E given that recent industry acquisitions for similar businesses are closer to 15x. CVS is an obvious target for the industry consolidators. Shares trading on a PE of 10.7x and 8.1x EV/Ebitda to Jun 2020

12:05 pm
BE
That's Charles Hall at Peel Hunt.
BE
"an obvious target for the industry consolidators" .... like?
BE
I thought CVS itself was the consolidator.

12:06 pm
BE
And that the consolidation model with vets had all sorts of problems and dis-synergies, as we've banged on about here for what feels like decades.
BE
Anyway.
12:07 pm

edmondj
29/3/2019
13:02
I can't see anything in the results which justifies a +18% share price rise. What am I missing ?
ramridge
29/3/2019
10:35
Not sure I'm right but things look to be improving and it could easily be prey to someone while it's sub 1000p.
its the oxman
29/3/2019
08:50
I have to say I called that one wrong! lol You could be right, but wait until the next update to really see if things are on the mend.
bulltradept
29/3/2019
08:29
Guess it's relief that things are on the mend at least. Still issues but worst could now be over.
its the oxman
29/3/2019
07:36
Mmmmm result as expected unfortunately.
bulltradept
23/3/2019
18:15
I always take Glassdoor reviews with a pinch of salt. They tend to be the spurned workers who have an axe to grind which does not offer a balanced picture.

There are some specific fundamentals that need to be demonstrated by the firm, internal management. Externalities like US data points will prob result in my increasing in stake if negative sentiment dislocates potential growth. But the growth here is all down to execution.. and that so be a critical watch point.

j0sekl
14/3/2019
13:35
Sold a few and made a bit back. Mars are a very different and mature business in this marketplace. You can’t benchmark CVS as a Mars they are way off and my hope is for a takeover for my remainder. May bail before financial results hit as all the predictions for this firm look very gloomy. The US market is very different to the UK the PE space is crowded and the panic buying PFM shares by directors to give faith to investors should send out alarm bells. But will bump the price up prior to the results.
mccookie
01/3/2019
10:24
Why up? Acquisition continues in this hot space, JAB’s Acquire USA Compassion-First Pet Hospitals, which operates 41 veterinary hospitals and emergency clinics in the US, values the company at $1.2bn. And recently seems Goldman Sach increasing stakes in the company. The market cap of around 350million pounds seems undervalued if benchmarking to other recent deals.. Just look at MARS...
compoundinge
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older

Your Recent History

Delayed Upgrade Clock